iShares S&P 500 Value ETF (IVE)
| Assets | $50.48B |
| Expense Ratio | 0.18% |
| PE Ratio | 21.64 |
| Forward PE | 17.50 |
| Shares Out | 213.10M |
| Dividend | $3.61 (1.53%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Payout Frequency | Quarterly |
| Payout Ratio | 33.19% |
| Volume | 895,437 |
| Open | 234.26 |
| Previous Close | 236.48 |
| Day's Range | 234.23 - 236.75 |
| 52-Week Low | 203.15 |
| 52-Week High | 244.72 |
| Beta | 0.83 |
| Holdings | 439 |
| Inception Date | May 22, 2000 |
About IVE
Fund Home PageThe iShares S&P 500 Value ETF (IVE) is an exchange-traded fund that is based on the S&P 500 Value index. The fund tracks an index of primarily large-cap US stocks. The index uses three fundamental factors to select value stocks from the S&P 500 Index. IVE was launched on May 22, 2000 and is issued by BlackRock.
Top 10 Holdings
24.35% of assets| Name | Symbol | Weight |
|---|---|---|
| Apple Inc. | AAPL | 8.33% |
| Amazon.com, Inc. | AMZN | 3.99% |
| ExxonMobil Holdings Corporation | XOM | 2.27% |
| Walmart Inc. | WMT | 1.86% |
| Costco Wholesale Corporation | COST | 1.56% |
| Chevron Corporation | CVX | 1.40% |
| The Procter & Gamble Company | PG | 1.28% |
| Tesla, Inc. | TSLA | 1.28% |
| Merck & Co., Inc. | MRK | 1.21% |
| UnitedHealth Group Incorporated | UNH | 1.18% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Sep 15, 2026 | $0.93087 | Sep 18, 2026 |
| Jun 15, 2026 | $0.89932 | Jun 18, 2026 |
| Mar 17, 2026 | $0.78424 | Mar 20, 2026 |
| Dec 16, 2025 | $0.99498 | Dec 19, 2025 |
| Sep 16, 2025 | $0.86519 | Sep 19, 2025 |
| Jun 16, 2025 | $0.80972 | Jun 20, 2025 |
Performance
IVE had a total return of 14.87% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.63%.
News
Inside the Ticker: IVE vs. IWD
The ETF industry continues to gather record inflows in 2026. This demand has been met with a rapidly growing supply.
Two ETFs that have beaten value stock indexes with this simple approach
These funds steer clear of typical value metrics that are based on price ratios.
Why I'm Not Giving Up on Value Stocks
James Glassman explains why he still has faith in investing in value stocks.
Growth Themed ETFs Started The Year Strong
The market continues to be driven by mega cap stocks, notes Aniket Ullal. He discusses ETF trends for 2024.
Value stocks are on sale and growth stocks look overpriced, says Charlie Bobrinskoy
Charlie Bobrinskoy, vice chairman of Ariel Investments, joins 'The Exchange' to discuss growth stocks outperforming value due to recession fears, overpricing of tech stocks, and investment opportuniti...
Value right now is overweight cyclical in banks and energy, says Ariel's Charlie Bobrinskoy
Charlie Bobrinskoy, head of investment group at Ariel Investments, and Erik Jackson, EMJ Capital founder and president, join 'Closing Bell' to discuss the state of the value investing industry, value ...
Why value stocks will struggle to repeat their vast 2022 outperformance in 2023
Are so-called value stocks still living up to their name? Some aren't so sure.
Value will outperform growth as long as Fed remains hawkish, says Gabelli Funds' Kevin Dreyer
Kevin Dreyer, Gabelli Funds co-cio, joins 'Closing Bell: Overtime' to discuss why he thinks value will continue to outperform growth.
Shorter duration growth stocks are still opportunity plays, says Weatherbie's Josh Bennett
Joshua Bennett, Weatherbie Capital, joins 'Closing Bell: Overtime' to discuss opportunities currently in growth stocks.
Sanctuary Wealth's Jeff Kilburg on the sectors to be exposed to in 2022
Jeff Kilburg, CIO of Sanctuary Wealth and a CNBC Contributor, joins Worldwide Exchange to discuss his market outlook.
What investors and traders bought during Friday's sell-off
Webull CEO Anthony Denier, WallachBeth Capital managing director Andrew McOrmond and Old Mission head of ETF sales trading Harry Whitton share their insights on Friday's vicious sell-off with CNBC's B...
Delphi's Scott Black on whether there's a tug of war between growth and value
Scott Black from Delphi Management joins Closing Bell and predicts the market rally will continue as long as Covid doesn't lead to any more shutdowns or shortfalls.
Why this investor says to stick with the value trade
CNBC's Kelly Evans discusses whether the rebound in growth and tech stocks can last with David Katz, chief investment officer at Matrix Asset Advisors. To see more of the interview with Katz sign up f...
Don't Call the Value Rally Dead Just Yet. Here's Why.
Value stocks have pulled back from recent highs. Growth stocks have started to come back.
Why You Should Consider Value Stocks: All You Need To Know
Value-style stocks are well positioned to perform better than the rest of the market after falling behind growth-style stocks for the last 4 years. The conditions favoring value over growth are the be...
Three investment buckets look best with global growth ‘peaking,' $48 billion portfolio manager says
As the S&P 500 inches back to record highs, Thornburg Investment's Ben Kirby says there are lots of reasons to be optimistic heading into summer.
The Tell: Value stocks are so in favor they've become momentum stocks
It's the holy grail of quant investing, these analysts enthuse: cheap stocks with great earnings momentum, which in turn drives outperformance.
MarketWatch Premium: These investment newsletters' favorite value stocks have widely outpaced growth stocks
The "value" proposition still holds: Since November, the return on a basket of value stocks totals 53% compared with only 11% for the S&P 500.
Value is finally outpacing growth this year but will still falter long term, traders say
The growth vs. value debate rolls on as value stocks attempt yet another comeback.
This is a time to selectively add tech stocks to portfolio: Advisor
CNBC's Jon Fortt discusses the tech trade and markets with Xi Qiao of UBS Global Wealth Management and Phil Camporeale of J.P. Morgan Asset Management.
How investors can approach the growth-versus-value debate in 2021
Nancy Prial, Essex Investment Management, and David Katz, chief investment officer at Matrix Advisors, join "The Exchange" to discuss how investors can best play the growth versus value trade. For acc...